Hydroxysafflor Yellow A Phytosomes Administered via Intervaginal Space Injection Ameliorate Pulmonary Fibrosis in Mice
Open Access
- 12 November 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (11) , 1394
Abstract
Idiopathic pulmonary fibrosis is a fatal interstitial disease characterized by fibroblast proliferation and differentiation and abnormal accumulation of extracellular matrix, with high mortality and an increasing annual incidence. Since few drugs are available for the treatment of pulmonary fibrosis, there is an urgent need for high-efficiency therapeutic drugs and treatment methods to reduce the mortality associated with pulmonary fibrosis. The interstitium, a highly efficient transportation system that pervades the body, plays an important role in the occurrence and development of disease, and can be used as a new route for disease diagnosis and treatment. In this study, we evaluated the administration of hydroxysafflor yellow A phytosomes via intervaginal space injection (ISI) as an anti-pulmonary fibrosis treatment. Our results show that this therapeutic strategy blocked the activation of p38 protein in the MAPK-p38 signaling pathway and inhibited the expression of Smad3 protein in the TGF-β/Smad signaling pathway, thereby reducing secretion of related inflammatory factors, deposition of collagen in the lungs of mice, and destruction of the alveolar structure. Use of ISI in the treatment of pulmonary fibrosis provides a potential novel therapeutic modality for the disease.Keywords
Funding Information
- The Key Research Program of CAS (QYKJZD-SSW-SLH02, ZDBS-LY-SLH036)
- Key Research Program of Frontier Sciences of CAS (QYKJZD-SSW-SLH02, ZDBS-LY-SLH036)
This publication has 29 references indexed in Scilit:
- Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitroJournal of Pharmacy and Pharmacology, 2016
- An in vivo study of the biodistribution of gold nanoparticles after intervaginal space injection in the tarsal tunnelNano Research, 2016
- Hydroxysafflor Yellow A Attenuates Lymphostatic Encephalopathy‐induced Brain Injury in RatsPhytotherapy Research, 2012
- Interstitium: The next diagnostic and therapeutic platform in critical illnessCritical Care Medicine, 2010
- Pulmonary fibrosis: pathogenesis, etiology and regulationMucosal Immunology, 2009
- New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequencesActa Anaesthesiologica Scandinavica, 2003
- Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2001
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- The wound environment as a regulator of fibroblast phenotypeJournal of Surgical Research, 1991
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.Journal of Cell Biology, 1986